Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Didem Uzunaslan

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Current Medicinal Chemistry|February 11, 2015
Currently Used Biologic Agents in the Management of Behcet's SyndromeCaner Saygin, Didem Uzunaslan, Gulen Hatemi
Rheumatology (Oxford, England)|December 27, 2013
No appreciable decrease in fertility in Behçet's syndromeDidem Uzunaslan, Caner Saygin, Gulen Hatemi, et al.
Clinical and Experimental Rheumatology|March 24, 2015
Suicidal ideation among patients with Behçet's syndromeCaner Saygin, Didem Uzunaslan, Gulen Hatemi, et al.
Critical Reviews in Oncology/Hematology|June 13, 2013
Dendritic cell sarcoma: a pooled analysis including 462 cases with presentation of our case seriesCaner Saygin, Didem Uzunaslan, Mustafa Ozguroglu, et al.
Pathology Oncology Research : POR|June 4, 2015
Epithelial-Mesenchymal Transition Markers β-catenin, Snail, and E-Cadherin do not Predict Disease Free Survival in Prostate Adenocarcinoma: a Prospective StudyTumay Ipekci, Ferhat Ozden, Betul Unal, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|January 12, 2013
Novel use of propranolol for management of pain in children with vertebral hemangioma: report of two casesDidem Uzunaslan, Caner Saygin, Semih Gungor, et al.
Leukemia Research|April 12, 2014
A 17-year experience with ALL-BFM protocol in acute lymphoblastic leukemia: prognostic predictors and interruptions during protocolAida Koka, Caner Saygin, Didem Uzunaslan, et al.
Journal of Cancer Research and Clinical Oncology|May 28, 2013
Expression of MMP-1, MMP-9 and TIMP-2 in prostate carcinoma and their influence on prognosis and survivalFerhat Ozden, Caner Saygin, Didem Uzunaslan, et al.
World Journal of Hepatology|April 14, 2015
Skin cancer in immunosuppressed transplant patients: Vigilance mattersOzan Unlu, Emir Charles Roach, Alexis Okoh, et al.
International Journal of Clinical and Experimental Pathology|May 23, 2013
Primary central nervous system lymphoma in immunocompetent individuals: a single center experienceHilal Aki, Didem Uzunaslan, Caner Saygin, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Current Medicinal Chemistry|February 11, 2015
Currently Used Biologic Agents in the Management of Behcet's SyndromeCaner Saygin, Didem Uzunaslan, Gulen Hatemi
Rheumatology (Oxford, England)|December 27, 2013
No appreciable decrease in fertility in Behçet's syndromeDidem Uzunaslan, Caner Saygin, Gulen Hatemi, et al.
Clinical and Experimental Rheumatology|March 24, 2015
Suicidal ideation among patients with Behçet's syndromeCaner Saygin, Didem Uzunaslan, Gulen Hatemi, et al.
Critical Reviews in Oncology/Hematology|June 13, 2013
Dendritic cell sarcoma: a pooled analysis including 462 cases with presentation of our case seriesCaner Saygin, Didem Uzunaslan, Mustafa Ozguroglu, et al.
Pathology Oncology Research : POR|June 4, 2015
Epithelial-Mesenchymal Transition Markers β-catenin, Snail, and E-Cadherin do not Predict Disease Free Survival in Prostate Adenocarcinoma: a Prospective StudyTumay Ipekci, Ferhat Ozden, Betul Unal, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|January 12, 2013
Novel use of propranolol for management of pain in children with vertebral hemangioma: report of two casesDidem Uzunaslan, Caner Saygin, Semih Gungor, et al.
Leukemia Research|April 12, 2014
A 17-year experience with ALL-BFM protocol in acute lymphoblastic leukemia: prognostic predictors and interruptions during protocolAida Koka, Caner Saygin, Didem Uzunaslan, et al.
Journal of Cancer Research and Clinical Oncology|May 28, 2013
Expression of MMP-1, MMP-9 and TIMP-2 in prostate carcinoma and their influence on prognosis and survivalFerhat Ozden, Caner Saygin, Didem Uzunaslan, et al.
World Journal of Hepatology|April 14, 2015
Skin cancer in immunosuppressed transplant patients: Vigilance mattersOzan Unlu, Emir Charles Roach, Alexis Okoh, et al.
International Journal of Clinical and Experimental Pathology|May 23, 2013
Primary central nervous system lymphoma in immunocompetent individuals: a single center experienceHilal Aki, Didem Uzunaslan, Caner Saygin, et al.
Pageof 1